NEAT1 and colorectal carcinoma: Based on the NEAT1 expression level, overall survival (OS) time and survival status, we obtained a suitable cut‐off value of NEAT1 in 392 CRC patients (Figure S1A) using the cut‐off finder (https://molpath.charite.de/cutoff/load.jsp), among which NEAT1 was divided into high expression group and low expression group (Figure 1C).